Alfonso Fernando, Sandoval Jorge, Pérez-Vizcayno María J, Cárdenas Alberto, Gonzalo Nieves, Jiménez-Quevedo Pilar, Ibáñez Borja, Núñez-Gil Iván, Rivero Fernando, Escaned Javier, Fernández-Ortíz Antonio, Macaya Carlos
Hospital Universitario de La Princesa, Madrid, Spain.
Hospital Universitario San Carlos, Madrid, Spain.
Int J Cardiol. 2015 Jan 15;178:213-20. doi: 10.1016/j.ijcard.2014.10.139. Epub 2014 Oct 23.
Mechanisms of lumen gain during reinterventions in patients with drug-eluting stent (DES) in-stent restenosis (ISR) remain unsettled.
We sought to assess the mechanisms of acute lumen gain after balloon angioplasty (BA) and repeat drug-eluting stent (DES) implantation in patients with DES-ISR. Following a prospective protocol 29 consecutive patients with DES-ISR were sequentially treated with BA and new DES implantation under a multimodality intracoronary imaging assessment including intravascular ultrasound (IVUS) and optical coherence tomography (OCT). Imaging studies were systematically obtained, at baseline, after BA, and after DES. Results of interventions were compared using volumetric and morphometric (ISR pattern and injury score) analyses.
IVUS and OCT demonstrated that acute lumen gain after BA and DES equally results from a reduction in intra-stent neointimal volume and further DES expansion. As compared with BA, repeat DES implantation not only increased final lumen (baseline 39.6±18.5mm(3), post-BA 58.6±26.6mm(3), post-DES 84.2±30.8mm(3), all p<0.001) but also provided a smoother lumen (injury score 1.57±0.86 vs 0.22±0.26, p<0.001). At the 9th month of angiographic follow-up (86% patients) in-stent late loss was 0.44±0.5mm and 4 patients (16%) developed ISR. The ISR pattern on OCT was not associated with the injury score after interventions or late angiographic findings. Likewise, the injury score did not predict late angiographic outcome.
In patients with DES ISR, lumen gain equally results from a reduction in intra-stent neointimal volume and further DES expansion. As compared with BA, repeat DES implantation provides a larger and smoother coronary lumen.
药物洗脱支架(DES)置入后支架内再狭窄(ISR)患者再次干预时管腔增加的机制仍未明确。
我们试图评估DES-ISR患者球囊血管成形术(BA)和再次药物洗脱支架(DES)植入后急性管腔增加的机制。按照前瞻性方案,对29例连续的DES-ISR患者在多模态冠状动脉内成像评估(包括血管内超声(IVUS)和光学相干断层扫描(OCT))下依次进行BA和新的DES植入治疗。在基线、BA后和DES后系统地进行成像研究。使用体积分析和形态学分析(ISR模式和损伤评分)比较干预结果。
IVUS和OCT显示,BA和DES后的急性管腔增加同样源于支架内新生内膜体积的减少和DES的进一步扩张。与BA相比,再次DES植入不仅增加了最终管腔(基线时39.6±18.5mm³,BA后58.6±26.6mm³,DES后84.2±30.8mm³,所有p<0.001),而且提供了更平滑的管腔(损伤评分1.57±0.86对0.22±0.26,p<0.001)。在血管造影随访的第9个月(86%的患者),支架内晚期管腔丢失为0.44±0.5mm,4例患者(16%)发生ISR。OCT上的ISR模式与干预后的损伤评分或晚期血管造影结果无关。同样,损伤评分也不能预测晚期血管造影结果。
在DES-ISR患者中,管腔增加同样源于支架内新生内膜体积的减少和DES的进一步扩张。与BA相比,再次DES植入可提供更大且更平滑的冠状动脉管腔。